Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

896
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
896
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

616
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
616
Seizures: Classification01:13

Seizures: Classification

1.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.0K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

696
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
696

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intestinal microbial community assessment in patients with different forms of epilepsy and autoimmune encephalitis: An exploratory study.

Gut microbes reports·2026
Same author

The Lancet Commission on precision health: equitable, data-driven health outcomes for all.

Lancet (London, England)·2026
Same author

Physicochemical Characterization and Metabolites Identification of the Synthetic Cannabinoid MDMB-5'Br-PINACA Using <i>In Silico</i> and <i>In Vitro</i> Approaches.

Chemical research in toxicology·2026
Same author

Dynamic structural and metabolic changes during the epileptogenesis in the pilocarpine model of temporal lobe epilepsy: A longitudinal MRI study.

Brain research·2026
Same author

Shared genetic architecture of brain age gap across 30 cohorts worldwide.

medRxiv : the preprint server for health sciences·2026
Same author

The HUGO Clinical Genomics & Genomic Medicine Education Survey: clinicians globally need and want genomic medicine training.

Human genomics·2025

Related Experiment Video

Updated: Nov 20, 2025

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.8K

Neuroproteomics in Epilepsy: What Do We Know so Far?

Amanda M do Canto1,2, Amanda Donatti1,2, Jaqueline C Geraldis1,2

  • 1Department of Medical Genetics and Genomic Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.

Frontiers in Molecular Neuroscience
|January 25, 2021
PubMed
Summary
This summary is machine-generated.

Epilepsy affects 2% of the global population, presenting treatment challenges due to medication resistance. Recent proteomic studies offer new insights into epilepsy mechanisms and potential therapeutic strategies.

Keywords:
epileptogenesishippocampal sclerosismalformations of cortical developmentmesial temporal lobe epilepsyproteomicsseizures

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.4K
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

15.1K

Related Experiment Videos

Last Updated: Nov 20, 2025

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.8K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.4K
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

15.1K

Area of Science:

  • Neurology
  • Proteomics
  • Molecular Biology

Background:

  • Epilepsies are chronic neurological disorders affecting 2% of the global population.
  • Current antiseizure medications are ineffective for a significant proportion of patients, causing substantial socioeconomic burdens.
  • Epileptic seizures stem from abnormal neuronal discharges, often linked to an imbalance between neuronal excitation and inhibition.

Purpose of the Study:

  • To review recent proteomic studies investigating the underlying mechanisms of epilepsy.
  • To explore how proteomic findings can inform future research and treatment of epilepsy.

Main Methods:

  • Review of recent proteomic studies focused on epilepsy.
  • Analysis of molecular mechanisms implicated in epileptogenesis.

Main Results:

  • Proteomic studies have identified key molecular players and pathways involved in epilepsy.
  • These findings shed light on the complex pathophysiology of seizure generation and epilepsy development.
  • Understanding these molecular underpinnings is crucial for developing targeted therapies.

Conclusions:

  • Proteomics offers a powerful lens to unravel the complexities of epilepsy.
  • Advances in proteomic research hold promise for improving treatment strategies and patient outcomes for epilepsy.